McKenney, A., Lau, A., Somasundara, A., Spitzer, B., Intlekofer, A., Ahn, J., … Levine, R. (2018). JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition. The Journal of Clinical Investigation. https://doi.org/10.1172/JCI94516 (Original work published 2018)